Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- Behavioral: Exposure and Response Prevention
- Registration Number
- NCT02062658
- Lead Sponsor
- New York State Psychiatric Institute
- Brief Summary
This study investigates if a single dose of IV Ketamine can rapidly improve Obsessive-Compulsive Disorder (OCD) symptoms and whether these effect can be maintained with a condensed course of a type of Cognitive Behavioral Therapy called Exposure and Response Prevention (EX/RP). You will be compensated for your time and travel. Participants must be between the ages of 18-55.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
- Age 18-55
- Physically healthy and not currently pregnant
- Primary Diagnosis of OCD
- Sufficient severity of symptoms
- Currently off all psychotropic medication OR
- Currently on adequate dose of medication for treatment of OCD, but have not achieved at least partial remission
- Able to provide consent
- Psychiatric conditions that make participation unsafe (schizophrenia [either self or first degree relative e.g. siblings, parents], history of violence, severe depression, eating disorder, substance dependence [including nicotine])
- Female patients who are either pregnant or nursing
- Planning to commence EX/RP during the period of the study or those who have completed an adequate dose of EX/RP (defined as 8 or more sessions within 2 months) within 8 weeks prior to enrollment.
period of the study
- Allergy to ketamine
- Participants for whom being off of medication is not clinically recommended
- Medical conditions that make participation unsafe (e.g. high blood pressure, head injury)
- Currently on medications that make participation unsafe
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Ketamine, Exposure & Response Prevention Exposure and Response Prevention 0.5mg/kg IV Ketamine infusion followed by condensed course of Exposure and Response Prevention (EX/RP) Ketamine, Exposure & Response Prevention Ketamine 0.5mg/kg IV Ketamine infusion followed by condensed course of Exposure and Response Prevention (EX/RP)
- Primary Outcome Measures
Name Time Method Number of Patients Who Met and Exceeded Response Criteria of Yale-Brown Obsessive-Compulsive Scale 2 weeks Patients given YBOCS (Yale Brown Obsessive-Compulsive Scale), a gold standard measure of obsessions and compulsions. For the YBOCS the minimum units are 0 and Maximum units on the total scale are 40. The higher the number on the YBOCS, the more severe the symptoms. Response was defined as at least a 35% reduction on the YBOCS.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
New York State Psychiatric Insitute
🇺🇸New York, New York, United States